Lee, Eun Sook; Shin, Jung Min; Son, Soyoung; Ko, Hyewon; Um, Wooram; Song, Seok Ho; Lee, Jae Ah; Park, Jae Hyung
Advanced healthcare materials
2019Jan ; 9 ( 1 ) :e1801320.
PMID : 30666822
ÀúÀÚ »ó¼¼Á¤º¸
Lee, Eun Sook -
Shin, Jung Min -
Son, Soyoung -
Ko, Hyewon -
Um, Wooram -
Song, Seok Ho -
Lee, Jae Ah -
Park, Jae Hyung -
ABSTRACT
Immunotherapy has emerged as a promising approach to treat cancer, since it facilitates eradication of cancer by enhancing innate and/or adaptive immunity without using cytotoxic drugs. Of the immunotherapeutic approaches, significant clinical potentials are shown in cancer vaccination, immune checkpoint therapy, and adoptive cell transfer. Nevertheless, conventional immunotherapies often involve immune-related adverse effects, such as liver dysfunction, hypophysitis, type I diabetes, and neuropathy. In an attempt to address these issues, polymeric nanomedicines are extensively investigated in recent years. In this review, recent advances in polymeric nanomedicines for cancer immunotherapy are highlighted and thoroughly discussed in terms of 1) antigen presentation, 2) activation of antigen-presenting cells and T cells, and 3) promotion of effector cells. Also, the future perspectives to develop ideal nanomedicines for cancer immunotherapy are provided. CI - ??2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
keyword
biomaterials; cancer; immunotherapy; nanomedicine; polymers
¸µÅ©